Previous reports have indicated that hypertensive patients who have angina-like chest pain and normal coronary arteriograms have reduced coronary flow velocity reserve (CFVR) levels. In addition, elevated plasma endothelin-1 (ET-1) levels have been reported to be associated with microvascular angina. The purpose of this study was to evaluate the plasma ET-1 levels and CFVR in patients with chest pain but without coronary artery disease (CAD). A total of 66 patients were included in this study. CAD was ruled out by exercise stress test or coronary angiogram. Plasma ET-1 and CFVR measurements were performed in patients with (n=35) and without (n=31) a history of angina-like chest pain. CFVR was measured using adenosine-triphosphate stress transthoracic Doppler echocardiography. The mean ET-1 level was significantly higher and the CFVR was significantly lower in patients in the symptomatic group than in those in the asymptomatic group (ET-1: 3.85±1.24 pg/ml vs. 2.98±1.27 pg/ml, CFVR: 2.26±0.48 vs. 2.77±0.11, respectively). Plasma ET-1 level and CFVR were significantly correlated with each other (−r=0.265, p=0.033). Age, blood pressure, cardiovascular risk factors, and left ventricular mass index were similar between the two groups. The results of multiple regression analysis indicate that age (p=0.008) and plasma ET-1 concentration (p=0.031) had statistically independent associations with CFVR. Attenuated CFVR in the symptomatic hypertensive patients was associated with endothelial dysfunction, which results in elevated plasma ET-1 levels. The link between these two parameters may play a role in the genesis of chest pain in hypertensive patients without CAD.
Opherk D, Mall G, Zebe H, et al: Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1–7.
Brush JE Jr, Cannon RO 3rd, Schenke WH, et al: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302–1307.
Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A : Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35: 1654–1660.
Panza JA : Myocardial ischemia and the pains of the heart. N Engl J Med 2002; 346: 1934–1935.
Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P : Vasotonic angina: a spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation. J Am Coll Cardiol 1993; 22: 417–425.
Cox ID, Botker HE, Bagger JP, Sonne HS, Kristensen BO, Kaski JC : Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol 1999; 34: 455–460.
Hoffmann E, Assennato P, Donatelli M, Colletti I, Valenti TM : Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms. Am Heart J 1998; 135: 684–688.
Kaski JC, Cox ID, Crook JR, et al, Coronary Artery Disease Research Group : Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Am Heart J 1998; 136: 412–417.
Kaski JC, Elliott PM, Salomone O, et al: Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620–624.
Artigou JY, Salloum J, Carayon A, et al: Variations in plasma endothelin concentrations during coronary spasm. Eur Heart J 1993; 14: 780–784.
Hozumi T, Yoshida K, Akasaka T, et al: Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998; 32: 1251–1259.
Takiuchi S, Rakugi H, Fujii H, et al: Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 2003; 26: 945–951.
Takiuchi S, Rakugi H, Masuyama T, et al: Hypertension attenuates the efficacy of hypoglycemic therapy for preserving coronary flow reserve in patients with type 2 diabetes. Hypertens Res 2002; 25: 893–900.
Hozumi T, Yoshida K, Ogata Y, et al: Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97: 1557–1562.
Branwald E : The history. in Branwald E, Zipes DP, Libby P ( eds): Heart Disease, 6th ed. Philadelphia: W.B. Saunders Co., 2001, pp 30–31.
Matsumura Y, Hozumi T, Watanabe H, et al: Department of internal cut-off value of coronary flow velocity reserve by transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery stenosis in patients with coronary risk factors. Am J Cardiol 2003; 92: 1389–1393.
Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.
Palombo C, Kozakova M, Magagna A, et al: Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000; 18: 453–459.
Kozàkovà M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A : Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551–559.
Antony I, Nitenberg A, Foult JM, Aptecar E : Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22: 514–520.
Sasaki O, Hamada M, Hiwada K : Effects of coronary blood flow on left ventricular function in essential hypertensive patients. Hypertens Res 2000; 23: 239–245.
Maseri A, Crea F, Kaski JC, Crake T : Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17: 499–506.
Piatti P, Fragasso G, Monti LD, et al: Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol 1999; 34: 1452–1460.
Takiuchi S, Fujii H, Kamide K, et al: Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens 2004; 9: 802–808.
Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415.
Miyauchi T, Tomobe Y, Shiba R, et al: Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990; 81: 1874–1880.
MacCarthy PA, Pegge NC, Prendergast BD, Shah AM, Groves PH : The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol 2001; 37: 137–143.
Cox ID, Salomone O, Brown SJ, Hann C, Kaski JC : Serum endothelin levels and pain perception in patients with cardiac syndrome X and in healthy controls. Am J Cardiol 1997; 80: 637–640.
Huelmos A, Garcia Velloso MJ, Maceira A : Myocardial perfusion reserve and endothelin plasmatic levels in asymptomatic patients with cardiovascular risk factors. Eur Heart J 1997; 18 ( Suppl): 435 ( Abstract).
Cannon RO 3rd, Balaban RS : Chest pain in women with normal coronary angiograms. N Engl J Med 2000; 342: 885–887.
Merz CN, Kelsey SF, Pepine CJ, et al: The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453–1461.
Rosano GM, Collins P, Kaski JC, Lindsay DC, Sarrel PM, Poole-Wilson PA : Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995; 16: 610–614.
About this article
Cite this article
Fujii, H., Takiuchi, S., Kamide, K. et al. Clinical Implications of Assessing Coronary Flow Velocity Reserve and Plasma Endothelin-1 in Hypertensive Patients. Hypertens Res 28, 911–916 (2005). https://doi.org/10.1291/hypres.28.911
- coronary flow velocity reserve
- endothelial function
- coronary artery disease
Clinical and Experimental Nephrology (2019)
Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts
Hypertension Research (2011)